Deep Track Capital, LP 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:12 am Purchase | 2024-09-30 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital, LP | 15,272,172 5.740% | 3,402,875 (+28.67%) | Filing |
| 2024-02-14 08:37 am Sale | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital, LP | 11,869,297 6.820% | -3,130,703 (-20.87%) | Filing |
| 2023-02-14 08:30 am Unchanged | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital, LP | 15,000,000 8.670% | 0 (Unchanged) | Filing |
| 2022-12-19 4:11 pm Purchase | 2022-12-09 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital, LP | 15,000,000 9.030% | 15,000,000 (New Position) | Filing |